Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radiosensitizing effect of misonidazole in acute and fractionated irradiation of a human osteosarcoma xenograft. [/sup 60/Co]

Conference · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
OSTI ID:6784041

The radiosensitizing effect of misonidazole (Ro-07-0582) in acute and fractionated irradiation of a human osteosarcoma grown in the athymic mutant nude mouse was studied. Tumor regrowth delay was used as a measure of response. The enhancement ratio of misonidazole was found to be 1.45 for an actue dose of 12.50 Gy and 1.25 for four fractions of 3.75 Gy, delivered over four consecutive days. It is concluded that the present osteosarcoma xenograft reoxygenated inadequately during the three day period which elapsed from the first to the fourth fraction of 3.75 Gy.

Research Organization:
Norwegian Radium Hospital, Montebello
OSTI ID:
6784041
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 6:9; ISSN IOBPD
Country of Publication:
United States
Language:
English

Similar Records

Response of a transplantable tumor to fractionated irradiation. I. X-rays and the hypoxic cell radiosensitizer Ro-07-0582
Journal Article · Wed Mar 31 23:00:00 EST 1976 · Radiat. Res.; (United States) · OSTI ID:7360032

Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice
Journal Article · Wed Jul 01 00:00:00 EDT 1981 · Invest. Urol.; (United States) · OSTI ID:5576365

Mechanism of binding of the radiosensitizers metronidazole and misonidazole (RO-07-0582) to bovine and human serum albumin: a proton NMR study
Journal Article · Wed Dec 31 23:00:00 EST 1980 · Radiat. Res.; (United States) · OSTI ID:6596387